Moleculin Announces Pricing Of $67.8 Million Underwritten Public Offering

Go back to Moleculin Announces Pricing Of $67.8 Million Underwritten Public Offering
METABASIS THERAPEUT (NASDAQ: MBRX) Delayed: 0.86 +0.03 (3.61%)
Previous Close $0.83    52 Week High $9.58 
Open $0.85    52 Week Low $2.34 
Day High $0.86    P/E N/A 
Day Low $0.85    EPS $-0.34 
Volume 141,893